Skip to main content
Clinical Trials/CTRI/2023/07/055121
CTRI/2023/07/055121
Recruiting
Phase 2

A Clinical Trial To Evaluate The Effectiveness Of Duralabhadi Kashaya In The Management Of Urinary Tract Infections. - NI

I0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
I
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
I

Eligibility Criteria

Inclusion Criteria

  • 1\)Subjects of either gender between age group 20\-60 yrs 2\)Subjects diagnosed with pus cell / bacteria in urine routine examination
  • 3\)Subjects diagnosed on basis of diagnostic parameters 4\)Subjects willing to sign the consent form and agreeing to follow the protocol of the study

Exclusion Criteria

  • 1\)Subjects with known case of impaired renal function
  • 2\)Subjects with known case of malignancy or tuberculosis of urinary tract
  • 3\)Subjects with known case of Diabetes Mellitus
  • 4\)Subjects with known case of Urolithiasis
  • 5\)Women those who are pregnant and breast feeding

Outcomes

Primary Outcomes

Not specified

Similar Trials